Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients

被引:67
作者
D'Aniello, A
Fisher, G
Migliaccio, N
Cammisa, G
D'Aniello, E
Spinelli, P
机构
[1] Staz Zool Anton Dohrn, Dept Neurobiol, I-80121 Naples, Italy
[2] Barry Univ, Dept Chem, Miami Shores, FL 33161 USA
[3] Ctr Polidiagnost Igea S Antimo, Lab Clin Anal, I-80029 S Antimo, Italy
关键词
amino acids; transaminases; human CSF; human brain; Alzheimer disease;
D O I
10.1016/j.neulet.2005.06.030
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study was conducted to determine the concentration of amino acids in the cerebrospinal spinal fluid (CSF) and the activities of two tramsaminases: glutamic oxaloacetate transaminase (GOT) and glutamic pyruvate transaminase (GPT) in human Alzheimer disease (AD) and normal brain. L-Glutamic acid, L-glutamine and L-alanine are the most abundant amino acids in the CSF (50-55% of total amino acids). L-Glutamine occurs at much higher levels in Alzheimer CSF compared to the normal CSF (229 +/- 91.8 nmol/ml in AD versus 107 +/- 47.2 nmol/ml in normal; P=0.0041). In contrast, L-aspartate occurs at significantly lower concentrations in Alzheimer CSF than normal CSF (46.1 +/- 25.7 nmol/ml in Alzheimer versus 95.2 +/- 52.6 nmol/ml in normal; P=0.020). In Alzheimer brain (frontal, parietal and occipital cortices) GOT is present at significantly higher activities than in normal brain cortices (about 1.5 times higher; P<0.01). No significant differences for GPT activity occurred between normal and AD brain. Since CSF receives amino acids from brain tissues, and since GOT catalyzes the conversion of L-aspartate to L-glutamate, the higher concentrations Of L-glutamine (which is derived from L-glutamate), and the lower concentrations of L-aspartate found in Alzheimer CSF could be considered as a consequence of the higher activity of GOT that occurs in Alzheimer brain. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 19 条
[1]  
*COMM ENZ SCAND SO, 1974, J CLIN LAB INVEST, V33, P287
[2]   Occurrence of D-aspartic acid and N-methyl-D-aspartic acid in rat neuroendocrine tissues and their role in the modulation of luteinizing hormone and growth hormone release [J].
D'Aniello, A ;
Di Fiore, MM ;
Fisher, GH ;
Milone, A ;
Seleni, A ;
D'Aniello, S ;
Perna, AF ;
Ingrosso, D .
FASEB JOURNAL, 2000, 14 (05) :699-714
[3]   AMINO-ACID CONCENTRATIONS IN CEREBROSPINAL-FLUID IN PRESENILE AND SENILE DEMENTIA OF ALZHEIMER TYPE AND MULTI-INFARCT DEMENTIA [J].
DEGRELL, I ;
HELLSING, K ;
NAGY, E ;
NIKLASSON, F .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1989, 9 (02) :123-135
[4]  
ELISON DW, 1986, ANN NEUROL, V20, P616
[5]   Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects [J].
Fisher, G ;
Lorenzo, N ;
Abe, H ;
Fujita, E ;
Frey, WH ;
Emory, C ;
Di Fiore, MM ;
D'Aniello, A .
AMINO ACIDS, 1998, 15 (03) :263-269
[6]  
GELOT MA, 1990, ANN BIOL CLIN-PARIS, V48, P182
[7]   DIAGNOSIS OF ALZHEIMERS-DISEASE [J].
KHACHATURIAN, ZS .
ARCHIVES OF NEUROLOGY, 1985, 42 (11) :1097-1104
[8]   AMINO-ACID-CONCENTRATIONS IN CEREBROSPINAL-FLUID AND SERUM IN ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA [J].
MARTINEZ, M ;
FRANK, A ;
DIEZTEJEDOR, E ;
HERNANZ, A .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1993, 6 (01) :1-9
[9]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[10]   INTRALAMINAR NEUROCHEMICAL DISTRIBUTIONS IN HUMAN MID-TEMPORAL CORTEX - COMPARISON BETWEEN ALZHEIMERS-DISEASE AND THE NORMAL [J].
PERRY, EK ;
ATACK, JR ;
PERRY, RH ;
HARDY, JA ;
DODD, PR ;
EDWARDSON, JA ;
BLESSED, G ;
TOMLINSON, BE ;
FAIRBAIRN, AF .
JOURNAL OF NEUROCHEMISTRY, 1984, 42 (05) :1402-1410